Clinical Trial Update: Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine [Phase 3]

View source ↗

Summary

Phase 3 lot-consistency trial of Sabin strain inactivated polio vaccine (IPV) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Sabin strain inactivated polio vaccine (inactivated polio vaccine (Sabin strain))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED